BioSpace News Archive

Business

Vaccitech Oncology Limited enters collaboration with Cancer Research UK to fund a Phase I/IIa clinical trial as first-line NSCLC therapy

Vaccitech Ltd announced that its strategic collaboration with the Ludwig Institute for Cancer Research, Vaccitech Oncology Limited, has entered into a clinical partnership with Cancer Research UK to develop VOLT’s VTP-600 immunotherapy as a treatment option for patients with non-small cell lung cancer.

December 19, 2019
·
7 min read
Drug Development

Topas Therapeutics Announces First Patient Enrolled in Phase 1 Trial with TPM203 in Pemphigus Vulgaris

Topas Therapeutics GmbH announced that the first patient has been enrolled in a first-in-human Phase 1 trial evaluating TPM203 in patients with pemphigus vulgaris, an orphan autoimmune disease.

December 19, 2019
·
4 min read
Deals

Genomill Health Closes Investment Round To Expand Beta-testing With Liquid Biopsy Players

Genomill Health closes a financing round led by a deep tech VC Voima Ventures to expand its novel and disruptive technology, focusing on efficient use of NGS in liquid biopsies for cancer diagnostics.

December 19, 2019
·
3 min read
Business

Sartorius Establishes Scientific Advisory Board

Sartorius, a leading international partner of life science research and the biopharmaceutical industry, announced that it established a Scientific Advisory Board for its Corporate Research activities.

December 19, 2019
·
4 min read
Business

E-Scape Bio Appoints Anthony Rimac as Chief Financial Officer and Ann Kapoun, Ph.D., as SVP of R&D

E-Scape Bio, Inc., a clinical stage, privately held biopharmaceutical company developing novel, precisely-targeted therapeutics for genetically-defined neurodegenerative diseases, announced the appointment of Tony Rimac as Chief Financial Officer and Ann Kapoun, Ph.D., as SVP of R&D.

December 19, 2019
·
2 min read
Genetown

FORMA Therapeutics Announces Closing of $100 Million Series D Financing

FORMA Therapeutics, Inc., a clinical stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced the closing of $100 million Series D financing

December 19, 2019
·
3 min read
Business

Rite Aid Corporation Reports Fiscal 2020 Third Quarter Results

Third Quarter Net Income from Continuing Operations of $52.3 Million or $0.98 Per Share, Compared to the Prior Year Third Quarter Net Loss of $17.3 Million or $0.33 Per Share

December 19, 2019
·
31 min read
Genetown

Agenus Commences Combination Trial of its Next-Gen CTLA-4 with its PD-1 Antibody

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, adoptive cell therapies1 and cancer vaccines, today announced the first patient dosed with AGEN1181, an anti-CTLA-4 antibody, in combination with balstilimab, Agenus’ PD-1 inhibitor.

December 19, 2019
·
4 min read
Pharm Country

IVERIC bio to Host an R&D Investor Symposium on Tuesday, January 14, 2020 in San Francisco, CA

IVERIC bio, Inc. (Nasdaq: ISEE) today announced details for its R&D Investor Symposium being held in San Francisco on Tuesday, January 14, 2020, from 6:30 a.m. to 8:00 a.m. Pacific Time.

December 19, 2019
·
2 min read
Business

Catalyst Biosciences Announces Global License and Collaboration Agreement to Develop Pegylated CB 2782 for the Treatment of Dry Age-Related Macular Degeneration

Catalyst to receive $15 million upfront and is eligible to receive an additional $340 million in milestones and tiered royalties up to low double digits

December 19, 2019
·
3 min read